Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2025
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
Stephanie J Lee, Brent Logan, Mary M Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2021
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies
Leo Luznik, Marcelo C Pasquini, Brent Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 8, 2019
Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial
Richard F Ambinder, Juan Wu, Brent Logan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2024
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial
Jason G Dehn, Brent Logan, Bronwen E Shaw, et al.
Transplantation and Cellular Therapy
|
January 17, 2026
Donor search and selection strategy to facilitate comparable transplant rates across donor search prognosis groups: A report from the BMT CTN 1702 trial
Joseph Pidala, Brent Logan, Stephanie J Lee, et al.
Transplantation and Cellular Therapy
|
November 10, 2025
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial
Jason G Dehn, Brent Logan, Stephanie J Lee, et al.
Transplantation and Cellular Therapy
|
June 10, 2022
The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials
Nosha Farhadfar, Kwang Woo Ahn, Stephanie Bo-Subait, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 4, 2026
IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients with Inborn Errors of Immunity from the Primary Immune Deficiency Treatment Consortium (PIDTC)
Danielle E Arnold, Hesham Eissa, Elizabeth Dunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2023
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401
David J Chung, Nina Shah, Juan Wu, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2025
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
Stephanie J Lee, Brent Logan, Mary M Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2021
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies
Leo Luznik, Marcelo C Pasquini, Brent Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 8, 2019
Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial
Richard F Ambinder, Juan Wu, Brent Logan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2024
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial
Jason G Dehn, Brent Logan, Bronwen E Shaw, et al.
Transplantation and Cellular Therapy
|
January 17, 2026
Donor search and selection strategy to facilitate comparable transplant rates across donor search prognosis groups: A report from the BMT CTN 1702 trial
Joseph Pidala, Brent Logan, Stephanie J Lee, et al.
Transplantation and Cellular Therapy
|
November 10, 2025
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial
Jason G Dehn, Brent Logan, Stephanie J Lee, et al.
Transplantation and Cellular Therapy
|
June 10, 2022
The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials
Nosha Farhadfar, Kwang Woo Ahn, Stephanie Bo-Subait, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 4, 2026
IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients with Inborn Errors of Immunity from the Primary Immune Deficiency Treatment Consortium (PIDTC)
Danielle E Arnold, Hesham Eissa, Elizabeth Dunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2023
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401
David J Chung, Nina Shah, Juan Wu, et al.
Page
of 10